[TVTX] YoY Quarter Result on 30-Sep-2018 [#Q3]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
01-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -144.15%
YoY- -206.37%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Revenue 68,217 51,139 44,373 40,706 40,340 33,945 28,005 15.98%
PBT -35,596 -22,526 -37,013 -54,101 -19,017 -30,646 144,339 -
Tax 43 23 -523 415 -1,223 6,467 38,761 -67.79%
NP -35,639 -22,549 -36,490 -54,516 -17,794 -37,113 105,578 -
Tax Rate - - - - - - -26.85% -
Total Cost 103,856 73,688 80,863 95,222 58,134 71,058 -77,573 -
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
NP Margin -52.24 -44.09 -82.23 -133.93 -44.11 -109.33 377.00 -
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
EPS -0.59 -0.44 -0.85 -1.34 -0.46 -1.00 2.95 -
EPS Diluted -0.59 -0.44 -0.85 -1.34 -0.46 -1.00 1.78 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.